• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

次黄嘌呤激活PI3K/AKT通路和脂质代谢,这是乳腺癌转移的特征。

Hypoxanthine activates PI3K/AKT pathway and lipid metabolism, hallmarks in breast cancer metastasis.

作者信息

Shakartalla Sarra B, Bouzid Amal, Altaie Alaa M, Ashmawy Naglaa S, Al Shareef Zainab M, Husseiny Mohamed I, Soliman Sameh S M

机构信息

Research Institute for Medical and Health Sciences, University of Sharjah, P.O. Box 27272, Sharjah, United Arab Emirates.

College of Medicine, University of Sharjah, P.O. Box 27272, Sharjah, United Arab Emirates.

出版信息

Med Oncol. 2025 Jun 16;42(7):263. doi: 10.1007/s12032-025-02829-8.

DOI:10.1007/s12032-025-02829-8
PMID:40522370
Abstract

Metastasis is the primary cause of death in women with breast cancer, which ranks among the most prevalent malignant diseases. Recently, we identified the significant metastatic role of hypoxanthine (HYP) in cancer cells. HYP is a naturally occurring purine derivative that actively participates in the synthesis of nucleic acids via the nucleotide salvage pathway. To gain a deeper insight onto the metastatic mechanism of HYP, integrated transcriptomics and metabolomics were conducted following the treatment of MCF-7 cells with HYP. HYP significantly activates PI3K/AKT pathway, a hallmark of cancer metastasis. Glycerolipid and fatty acid metabolisms are among the top-upregulated lipid metabolic pathways, while glycolysis is dysregulated. Seahorse real-time ATP rate analysis revealed a significant decrease in ATP production from the glycolysis pathway in HYP-treated cancer cells. On the other hand, genetic information processes including gene transcription and protein translation were downregulated. Collectively, our results highlight the contribution of HYP to cancer cell metastasis through the PI3K/AKT pathway. Consequently, manipulating HYP release could serve as a therapeutic target for the management of breast cancer.

摘要

转移是乳腺癌女性患者的主要死因,乳腺癌是最常见的恶性疾病之一。最近,我们发现次黄嘌呤(HYP)在癌细胞中具有重要的转移作用。HYP是一种天然存在的嘌呤衍生物,通过核苷酸补救途径积极参与核酸的合成。为了更深入地了解HYP的转移机制,在用HYP处理MCF-7细胞后进行了综合转录组学和代谢组学研究。HYP显著激活PI3K/AKT通路,这是癌症转移的一个标志。甘油脂质和脂肪酸代谢是上调最明显的脂质代谢途径,而糖酵解则失调。海马实时ATP速率分析显示,HYP处理的癌细胞中糖酵解途径产生的ATP显著减少。另一方面,包括基因转录和蛋白质翻译在内的遗传信息过程被下调。总的来说,我们的结果突出了HYP通过PI3K/AKT通路对癌细胞转移的作用。因此,控制HYP的释放可作为乳腺癌治疗的一个靶点。

相似文献

1
Hypoxanthine activates PI3K/AKT pathway and lipid metabolism, hallmarks in breast cancer metastasis.次黄嘌呤激活PI3K/AKT通路和脂质代谢,这是乳腺癌转移的特征。
Med Oncol. 2025 Jun 16;42(7):263. doi: 10.1007/s12032-025-02829-8.
2
Upregulated SAE1 Drives Tumorigenesis and Is Associated with Poor Clinical Outcomes in Breast Cancer.SAE1上调驱动肿瘤发生并与乳腺癌不良临床预后相关。
Breast J. 2024 Jun 30;2024:2981722. doi: 10.1155/2024/2981722. eCollection 2024.
3
Mutational analysis and protein expression of PI3K/AKT pathway in four mucinous cystadenocarcinoma of the breast.4例乳腺黏液性囊腺癌中PI3K/AKT通路的突变分析及蛋白表达
Diagn Pathol. 2025 May 28;20(1):68. doi: 10.1186/s13000-025-01650-1.
4
Evaluating the and effects of carvacrol zinc oxide quantum dots in breast cancer.评估香芹酚氧化锌量子点在乳腺癌中的[此处原文缺失部分内容]和效果。
J Biomater Sci Polym Ed. 2025 Apr;36(6):796-815. doi: 10.1080/09205063.2024.2429325. Epub 2024 Dec 3.
5
IGF-1 regulates LARP6-mediated collagen metabolism in vaginal fibroblasts of POP patients via the PI3K/AKT pathway.胰岛素样生长因子-1通过PI3K/AKT信号通路调控盆腔器官脱垂患者阴道成纤维细胞中LARP6介导的胶原代谢。
Sci Rep. 2025 Jul 1;15(1):21977. doi: 10.1038/s41598-025-08509-x.
6
The favorable impact of PIK3CA mutations on survival: an analysis of 2587 patients with breast cancer.PIK3CA突变对生存的有利影响:对2587例乳腺癌患者的分析
Chin J Cancer. 2012 Jul;31(7):327-34. doi: 10.5732/cjc.012.10032. Epub 2012 May 24.
7
Unveiling the omics tapestry of B-acute lymphoblastic leukemia: bridging genomics, metabolomics, and immunomics.揭示B细胞急性淋巴细胞白血病的组学图谱:连接基因组学、代谢组学和免疫组学。
Sci Rep. 2025 Jan 25;15(1):3188. doi: 10.1038/s41598-025-87684-3.
8
[Down-regulation of ACADM-mediated lipotoxicity inhibits invasion and metastasis of estrogen receptor-positive breast cancer cells].[ACADM介导的脂毒性下调抑制雌激素受体阳性乳腺癌细胞的侵袭和转移]
Nan Fang Yi Ke Da Xue Xue Bao. 2025 Jun 20;45(6):1163-1173. doi: 10.12122/j.issn.1673-4254.2025.06.06.
9
Aldo-keto Reductase 1B10 (AKR1B10) Suppresses Sensitivity of Ferroptosis in TNBC by Activating the AKT/GSK3β/Nrf2/GPX4 Axis.醛酮还原酶1B10(AKR1B10)通过激活AKT/GSK3β/Nrf2/GPX4轴抑制三阴性乳腺癌中铁死亡的敏感性。
Front Biosci (Landmark Ed). 2025 Jun 27;30(6):36615. doi: 10.31083/FBL36615.
10
A dynamic co-expression approach reveals Gins2 as a potential upstream modulator of HNSCC metastasis.一种动态共表达方法揭示Gins2是头颈部鳞状细胞癌转移的潜在上游调节因子。
Sci Rep. 2025 Jan 27;15(1):3322. doi: 10.1038/s41598-024-82668-1.

本文引用的文献

1
Metabolic reprogramming and synergistic cytotoxicity of genistein and chemotherapy in human breast cancer cells.染料木黄酮与化疗对人乳腺癌细胞的代谢重编程及协同细胞毒性作用
Life Sci. 2025 Jun 1;370:123562. doi: 10.1016/j.lfs.2025.123562. Epub 2025 Mar 14.
2
Strategic advancements in targeting the PI3K/AKT/mTOR pathway for Breast cancer therapy.针对PI3K/AKT/mTOR通路进行乳腺癌治疗的策略进展
Biochem Pharmacol. 2025 Jun;236:116850. doi: 10.1016/j.bcp.2025.116850. Epub 2025 Mar 4.
3
Regulation of PI3K signaling in cancer metabolism and PI3K-targeting therapy.
癌症代谢中PI3K信号通路的调控及PI3K靶向治疗
Transl Breast Cancer Res. 2024 Oct 29;5:33. doi: 10.21037/tbcr-24-29. eCollection 2024.
4
The PI3K/Akt Pathway and Glucose Metabolism: A Dangerous Liaison in Cancer.PI3K/Akt 通路与葡萄糖代谢:癌症中的危险勾结。
Int J Biol Sci. 2024 May 27;20(8):3113-3125. doi: 10.7150/ijbs.89942. eCollection 2024.
5
H-NMR metabolomics analysis identifies hypoxanthine as a novel metastasis-associated metabolite in breast cancer.H-NMR 代谢组学分析鉴定次黄嘌呤为乳腺癌中一种新的转移相关代谢物。
Sci Rep. 2024 Jan 2;14(1):253. doi: 10.1038/s41598-023-50866-y.
6
Monounsaturated Fatty Acids: Key Regulators of Cell Viability and Intracellular Signaling in Cancer.单不饱和脂肪酸:癌症中细胞活力和细胞内信号传导的关键调节因子
Mol Cancer Res. 2022 Sep 2;20(9):1354-1364. doi: 10.1158/1541-7786.MCR-21-1069.
7
Statins and endocrine resistance in breast cancer.他汀类药物与乳腺癌的内分泌抵抗
Cancer Drug Resist. 2021 Jun 19;4(2):356-364. doi: 10.20517/cdr.2020.112. eCollection 2021.
8
HMDB 5.0: the Human Metabolome Database for 2022.HMDB 5.0:2022 年人类代谢组数据库。
Nucleic Acids Res. 2022 Jan 7;50(D1):D622-D631. doi: 10.1093/nar/gkab1062.
9
Targeting PI3K/Akt signal transduction for cancer therapy.针对 PI3K/Akt 信号转导通路的癌症治疗策略。
Signal Transduct Target Ther. 2021 Dec 16;6(1):425. doi: 10.1038/s41392-021-00828-5.
10
Endocrine resistance in breast cancer: from molecular mechanisms to therapeutic strategies.乳腺癌内分泌耐药:从分子机制到治疗策略。
J Mol Med (Berl). 2021 Dec;99(12):1691-1710. doi: 10.1007/s00109-021-02136-5. Epub 2021 Oct 8.